vs
Side-by-side financial comparison of Cellyan Biotechnology Co., Ltd (HKPD) and Wellgistics Health, Inc. (WGRX). Click either name above to swap in a different company.
Wellgistics Health, Inc. is a U.S.-headquartered healthcare services firm focused on the distribution of prescription pharmaceuticals, over-the-counter medications, and medical supplies. Its key customer segments include retail pharmacies, long-term care facilities, and independent healthcare providers across the domestic market.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
Revenue
HKPD
WGRX
| Q4 25 | — | $1.7M | ||
| Q3 25 | — | $3.0M | ||
| Q2 25 | — | $7.8M | ||
| Q1 25 | — | $10.9M |
Net ProfitHKPDWGRX
| Q4 25 | — | $-27.9M | ||
| Q3 25 | — | $-34.3M | ||
| Q2 25 | — | $-6.7M | ||
| Q1 25 | — | $-32.4M |
Gross MarginHKPDWGRX
| Q4 25 | — | -470.2% | ||
| Q3 25 | — | 7.7% | ||
| Q2 25 | — | 6.5% | ||
| Q1 25 | — | 6.4% |
Operating MarginHKPDWGRX
| Q4 25 | — | -1517.5% | ||
| Q3 25 | — | -1047.1% | ||
| Q2 25 | — | -70.6% | ||
| Q1 25 | — | -288.6% |
Net MarginHKPDWGRX
| Q4 25 | — | -1667.2% | ||
| Q3 25 | — | -1139.0% | ||
| Q2 25 | — | -85.6% | ||
| Q1 25 | — | -298.5% |
EPS (diluted)HKPDWGRX
| Q4 25 | — | $-0.24 | ||
| Q3 25 | — | $-0.46 | ||
| Q2 25 | — | $-0.11 | ||
| Q1 25 | — | $-0.62 |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
